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Abstract: Biomaterials and neurotrophic factors represent promising guidance for neural 
repair. In this study, we combined poly-(lactic acid-co-glycolic acid) (PLGA) conduits and 
neurotrophin-3 (NT-3) to generate NT-3-loaded PLGA carriers in vitro. Bioactive NT-3 was 
released stably and constantly from PLGA conduits for up to 4 weeks. Neural stem cells (NSCs) 
and Schwann cells (SCs) were coseeded into an NT-releasing scaffold system and cultured for 
14 days. Immunoreactivity against Map2 showed that most of the grafted cells (.80%) were 
differentiated toward neurons. Double-immunostaining for synaptogenesis and myelination 
revealed the formation of synaptic structures and myelin sheaths in the coculture, which was 
also observed under electron microscope. Furthermore, under depolarizing conditions, these 
synapses were excitable and capable of releasing synaptic vesicles labeled with FM1-43 or 
FM4-64. Taken together, coseeding NSCs and SCs into NT-3-loaded PLGA carriers increased 
the differentiation of NSCs into neurons, developed synaptic connections, exhibited synaptic 
activities, and myelination of neurites by the accompanying SCs. These results provide an 
experimental basis that supports transplantation of functional neural construction in spinal 
cord injury.
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Introduction
Spinal cord injury (SCI) is a common medical problem, which can result in axonal 
demyelination, loss of both sensory and motor neuron function, and even neuronal 
damage and death.1 SCI triggers a cascade of events, including infiltration macrophages, 
activation of resident glial cells, and formation of cavities in the injury site.2 The patho-
logical process of SCI is complicated and involves multiple factors from different cell 
types, which results in a lack of effective treatment of the disease. Initial experimental 
approaches, which aimed to restore neuronal circuits in SCIs, focused on the use of 
cultured neurons and supporting cells to replace damaged areas of the tissue.3
Schwann cells (SCs), the myelin-forming cells of the peripheral nervous system, 
play a crucial role in nerve regeneration through production of neurotrophic growth 
factors and excretion of extracellular matrices.4,5 These features are suggestive of 
SCs’ therapeutic potential for spinal cord repair.3,6–8 It has been demonstrated that an 
SC-loaded scaffold can promote limited axonal regeneration, and modestly improve 
hind limb motor function.6,8 Nevertheless, keeping grafted SCs alive within the SCI 
site remains a challenge.6
Stem cell-based therapy for SCI has also attracted much attention since the 
discovery of neural stem cells (NSCs) in mammals.9,10 Implantation of cultured 
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NSCs was shown to enhance neuroprotection, stimulate 
neuroplasticity, and rescue neuronal loss in an experimental 
SCI model.11–13 However, effectiveness of NSC transplanta-
tion in CNS trauma remains limited for two reasons: firstly, 
grafted NSCs rarely differentiate into mature neurons in 
spinal cord lesions,14,15 and secondly, NSCs survive poorly 
when transplanted, which attenuates their effect on the 
restoration of neural circuits.16,17 Therefore, in order to 
adequately evaluate the therapeutic potential of NSCs in 
bridging a lesion gap in SCI, it is necessary to investigate 
regimens that further augment the survival and differentia-
tion of transplanted NSCs.
Neurotrophins (NTs) play important roles in neuronal 
survival, differentiation, and neurite outgrowth.18 NSCs 
transfected with NT-3,19 or seeded into the NT-3-chitosan 
carriers,13,20 yield a high percentage of differentiation toward 
neurons. Here, we engineered an NT-3-loaded poly-(lactic 
acid-co-glycolic acid) (PLGA) carrier, and tested whether 
coseeding NSCs and SCs into an NT-releasing scaffold 
system would permit grafted cells to survive, differentiate 
into neurons, myelinate, and then form a functional construct. 
Any such functional neural construction may be particularly 
useful as engineered nerve tissue replacement for SCI.
Materials and methods
Preparation of PLGA scaffold
A macroporous PLGA scaffold was synthesized with a 
75:25 monomer ratio (D,L-lactide: glycolide) by ring-
opening polymerization using Sn (Oct)2 as a catalyzer, and 
dodecanol as an initiator. The average molecular weight of 
the PLGA copolymer was 1.22 × 105 (Mn GPC). To obtain 
different pore sizes, polymer concentration was employed 
from 2.5% to 20%. Sodium chloride as a porogen was added 
into the polymer solution with PLGA/NaCl in a weight 
ratio of 1:9. The PLGA scaffold formed pores of varying 
sizes, ranging from a few µm up to 200 µm that were suit-
able for seeding neurospheres with diameters of 100 µm 
to 300 µm. PLGA rods with longitudinal parallel-channels 
were f  abricated by an injection molding, combined with 
thermally-induced phase separation. The lumens of the mold 
were pretreated with chlorotrimethylsilane, and were placed 
into the freezer at -40°C for at least 1 hour. A 5% (w/v) 
PLGA solution in 1,4-dioxane was rapidly injected into the 
cold mold with a syringe. Injection pressure at the port of 
the syringe was maintained by keeping it completely frozen 
until its introduction into the polymer solution. The mold was 
then placed in the freezer at -40°C for another 2 hours. The 
scaffold was then lyophilized under 0.940 mbar at 0°C for 
at least 4 days. The polymer scaffold was then trimmed into 
a rod shape 2 cm in length and 5 mm in diameter.
NSCs preparation and identification
Whole hippocampi aged 3–5 days from Sprague–Dawley 
(SD) rat pups were dissected and dissociated in Hanks’ 
  balanced salt solution (HBSS). After centrifuging at 
1000 rpm for 5 minutes, the supernatant was removed. The 
pellet was resuspended in 5 mL basal medium including: 
  Dulbecco’s modified Eagle’s medium (DMEM)/F12 at a 
ratio of 1:1, containing B27 supplement 20 µL/mL (Gibco, 
Carlsbad, CA) and basic fibroblast growth factor 20 ng/mL 
(Invitrogen, Carlsbad, CA). Cells were then plated onto 
75-mL culture flasks, with fresh medium every 3 days. 
  Cultured cells typically grew as suspending neurospheres 
and were passaged once per week.
SCs culture and purification
Cultured SCs were obtained from 3-day-old SD rats as 
described above.12 Sciatic nerves were harvested with 
0.25% trypsin for 15 minutes at 37°C followed by 0.16% 
collagenase (both trypsin and collagen; Sigma-Aldrich, St 
Louis, MO) for 20 minutes. Following harvest, cells were 
centrifuged at 1000 rpm for 5 minutes, resuspended in 
DMEM/F12 with 10% fetal bovine serum (FBS) (Invitrogen) 
and plated on poly-L-lysine 0.01% (Sigma-Aldrich)-coated 
plates at 1 × 105 cells/mL. The following day, these cells 
were treated with cytosine arabinoside (1 × 10-5 M; Sigma-
Aldrich) for 24–48 hours to rapidly remove fibroblasts. Cells 
were fed every 3–4 days and passaged every week. The 
purity of cultured SCs was   determined by immunostaining, 
using an antibody against the SC marker S-100, with DAPI 
(4’,6-diamidino-2-phenylindole; Invitrogen) as a counter 
stain. Purity of the SC cultures used for implantation in this 
study was at least 90%.
Preparation of NT-3-loaded PLGA 
carriers
Silk fibroin (SF), a fibrous protein biopolymer derived from 
the silkworm Bombyx mori, is widely used in protein-delivery 
systems.25,26 SF was prepared as described.25 Briefly, cocoons 
from B. mori were boiled in ultrapurified water (UPW) con-
taining 0.02 M Na2CO3, rinsed thoroughly with distilled water 
to extract the glue-like sericin proteins and wax, and then dis-
solved in 9M LiBr at 55°C to obtain a 10% aqueous SF (w/v) 
solution. Then, 10% aqueous SF solution was dialyzed with 
UPW and diluted into 1%, 3%, or 6% SF solution. Recombinant 
human NT-3 (PeproTech, Rocky Hill, NJ) was embedded by   
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adding 10 mg NT-3 to 1mL SF solution (1%, 3%, or 6%, 
respectively). NT-3-SF solution was subsequently sterilized 
by 0.25 µm filter (Invitrogen). PLGA rods were cut into 
2 mm slices, sterilized in 70% alcohol for 10 minutes, rinsed 
with sterile phosphate-buffered solution (PBS; pH 7.4) for 
30 minutes, soaked in NT-3-SF solution, stirred at 0°C for 
6 hours, air-dried under laminar airflow overnight, and subse-
quently treated with 70% alcohol for 5 minutes to render them 
insoluble by SF physical induction of β-sheet formation. The 
NT-3-loaded PLGA carriers were then stored in a dessicator 
and rinsed with sterile PBS for 30 minutes before use.
Kinetics of NT-3 release  
from NT-3-loaded PLGA carriers
Five independent samples of medium supernatants from 
PLGA carriers with different SF concentrations were collected 
at 1, 3, 6, 12, and 24 hours, between 1 and 5 weeks after the 
initiation of the coculture. Enzyme-linked immunosorbent 
assay (ELISA) (Becton Dickinson, Franklin Lakes, NJ) was 
performed according to the manufacturer’s instructions, in 
order to determine the kinetics of NT-3 released from NT-3-
loaded PLGA carriers. Absorbance was measured at 450 nm 
using a plate reader (Model 680; Bio-RAD, Hercules, CA), 
and NT-3 concentration was determined by comparing the 
reading to the standard curve.
NSCs and SCs seeding in PLGA scaffolds
NSCs from neurospheres were dissociated mechanically and 
mixed with SCs after counting cells on a hemocytometer. 
Cells were then suspended in basic medium (DMEM/F12 
with 10% FBS), and seeded under three separate conditions: 
PLGA only, PLGA-SF (3% SF solution), and PLGA-SF-
NT-3 (3% SF solution with NT-3). In order to seed neuro-
spheres into the scaffold, we put 3.1 × 106 cells in 20 mL 
culture medium consisting of DMEM/F12 at a ratio of 1:1, 
10% FBS, and 50 µg/mL ascorbic acid (Sigma-Aldrich) on 
top of PLGA slice with Waterman filter paper (#1) beneath 
the slice to gently suck cells into the pores. Slices were incu-
bated in 35 mm culture dishes for 14 days, with the culture 
medium replaced every 2 days.
Live–dead staining
After 14 days of culture, PLGA slices were rinsed with 0.1 M 
PBS (pH 7.4) for 30 minutes, followed by staining in 2 mL 
0.1 M PBS containing 2 mM of calcein-AM and 4 mM ethid-
ium homodimer (EthD-III) (Live/Dead Assay Kit; Invitrogen) 
for 1 hour at 37°C. Slices were then fixed with 4% formal-
dehyde and cryosectioned into 20 µm   continuous sections. 
Five sections from the peripheral edge of the PLGA slices 
(peripheral sections) and five sections from the center of the 
slices (center sections) were used for comparison. Live cells 
stained with calcein-AM showed a green color, and dead cells 
stained with EthD-III showed a red color under fluorescent 
microscopy. Cell death rate was calculated by determining the 
percentage of EthD-1-positive cells over the total number of 
cells from five randomly selected fields in each section.
Immunocytochemistry
Differentiation and synaptogenesis were determined using 
immunocytochemistry (ICC) staining of cryosections, fol-
lowing standard protocol. Antibodies used in this section 
included rabbit anti-γ-aminobutyric acid and rabbit anti-
glutamate, both at ratios of 1:300, mouse anti-Map2, rabbit 
anti-TuJ-1, rabbit anti-5-HT, and rabbit anti-MBP, all at 
ratios of 1:500, and also rabbit anti-glial fibrillary acidic 
protein and mouse anti-O4, again, both at ratios of 1:1000 
(all from Sigma-Aldrich), as well as mouse anti-PSD95 and 
rabbit anti-synapsin, both at ratios of 1:500 (both from Cell 
Signaling Technologies, Beverly, MA), and finally rabbit 
anti-ChAT and rabbit anti-S100, both at a ratio of 1:500 (both 
from Chemicon International, Inc, Billerica, MA).
Western blotting
PLGA slices for cell coculture were triturated using a fire-
polished glass pipette with 0.25% trypsin in 0.03% EDTA, 
which was then rinsed three times. Cells were collected and 
lysed in RIPA buffer (1 × PBS, 1% NP40, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulfate [SDS], plus the 
protease inhibitor, phenylmethylsulfonyl fluoride). The pro-
tein concentration in cell lysates was determined by a BCA 
protein assay kit (Pierce Protein Research Products; Thermo 
Fisher Scientific Inc, Rockford, IL). Whole cell lysates 
were separated by 10% SDS-polyacrylamide gel, followed 
by the standard Western blotting protocol using antibodies 
against TuJ-1 and anti-GFAP. Lysates from neonatal rat 
brains were used as a positive control. Signal intensity of 
the blots was measured using TotalLab software (Nonlinear 
USA Inc, D  urham, NC). All experiments were repeated three 
times, and the statistics were analyzed using SPSS software 
(version 11.5; SPSS, Chicago, IL).
Ultrastructural observation
PLGA scaffolds were fixed in 2% glutaraldehyde for 
90 minutes, osmicated with 1% osmic acid for 1 hour, and 
then dehydrated with a gradient concentration of ethanol. 
Samples were coated with platinum and examined under the 
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scanning electron microscope (SEM; Philips XL30 FEG; 
Philips, Eindhoven, The Netherlands) at 10 kV .
In preparation for viewing under transmission electron 
microscope (TEM; Philips CM 10; Philips), the PLGA-SF-
NT-3 scaffold was fixed with 2.5% glutaraldehyde at 4°C for 
30 minutes, followed by osmication and dehydration. The 
scaffolds were then embedded in epon overnight, followed 
by polymerization at 60°C for 48 hours. Use of acetone or 
epoxypropane was avoided, since PLGA is destroyed by these 
organic solvents. Ultrathin sections were obtained using the 
Reichert-Jung Ultracut E ultramicrotome (C. Reichert AG, 
Vienna, Austria) and examined under TEM.
Detection of synaptic activity
Grafted cells were cultured for 14 days in different PLGA 
scaffolds. Cells were then loaded with 10 µM FM1-43 
[(N-3-triethylammonmpropyl)-4-(4-(dibutylamino)styryl)] 
or 10 µM FM4-64 [N-(3-triethylammoniumpropyl)-4-(6-
(4-(diethylamino)phenyl) hexatrienyl)pyridiniumdibromide] 
(both from Invitrogen) under high K+ (50 mM) concentration 
for 10 minutes.21,22 High K+ levels stimulated recycling of 
endocytic synaptic vesicles containing FM1-43 or FM4-64. 
Scaffolds were then rinsed three times (for 15–20 minutes 
each time) in medium without FM1-43 or FM4-64, to bring 
endocytic/exocytotic activities to base level. This also 
eliminated nonspecific labeling of cytoplasmic membranes, 
but kept synaptic vesicles labeled by FM1-43 or FM4-64. 
Cells were then unloaded by induction of depolarization 
with high K+ for the second time. Release of FM1-43-or 
FM4-64-labeled synaptic vesicles was imaged under fluo-
rescent microscopy, using a Zeiss LSM 710 laser scanning 
microscope (Carl Zeiss Shanghai Co, Ltd, Beijing, China).
Analysis of MBP-positive fiber
Myelin basic protein (MBP), a marker of myelin sheaths, is 
important in the process of myelination. MBP-positive fibers 
were examined by single or costaining of PLGA sections with 
Map2 and MBP and visualized under fluorescent microscopy. 
For each experimental group, at least five fields of each section 
(including four corners and one center) were imaged. MBP 
signal spinning longer than 10 µm was considered as indica-
tion of the presence of MBP fibers. The percentage of positive 
fibers of each group was determined relative to the sum of 
positive ones. All experiments were repeated three times.
Statistical analysis
For quantification of cell types in any given experiment, at 
least five random fields were selected and photographed under 
20× lens. The percentage of positive cells was determined 
relative to the total number of DAPI-labeled cell nuclei. We 
counted about 500 cells in every group. Statistical analyses 
were performed using ANOVA for Student’s t-test. A P-value 
smaller than 0.05 was considered statistically significant.
Results
Culture of NSCs and SCs
NSCs and SCs were isolated from the whole hippocampi and 
sciatic nerves of rat pups. Cells were observed under phase-
contrast microscope 14 days later. SCs displayed character-
istic morphology, with spindle-shaped bodies and bipolar 
processes (arrow in Figure 1A). To determine the purity 
of cultured SCs, cells were immunostained with antibody 
against S100, a marker for SC. Approximately 95% of the 
cells were S100-positive (Figure 1B). NSCs were assessed 
with nestin, a marker for neural precursors. Immunostain-
ing results demonstrated that almost two-thirds of cultured 
cells were nestin-positive (Figure 1C, data not shown), 
B A
C
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15 kV ×200 100 µm PC-SEM PC-SEM 20 µm ×650 10 kV
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D
Figure  1  Schwann  cells  (SCs)  and  neural  stem  cells  (NSCs)  culture  and 
identification.  (A)  SCs  (arrow)  were  viewed  under  light  microscopy;  (B)  Cell 
bodies (arrow) were stained with antibodies against S100 and nuclei were labeled 
by DAPI; (C) Neurospheres were stained with antibodies against nestin, a marker 
of NSCs; (D) Nuclei in the neurosphere were labeled by DAPI. Scale bar = 20 µm 
in (A–B) and 10 µm in (C–D); (E) SEM of a transverse section of PLGA scaffold 
shows one of the tubes (arrow). There are numerous pores with variable diameters 
between tubes; (F) A longitudinal section of PLGA was imaged under high SEM.
Note: The arrow points to the radial channel that extends from the scaffold tube.
Abbreviations: DAPI, 4′,6-diamidino-2-phenylindole; SEM, scanning electron micro-
scope; PLGA, poly-(lactic acid-co-glycolic acid).
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and the nuclei were labeled by DAPI (Figure 1D). These 
NSCs and SCs were then grafted into the NT-3-loaded PLGA 
carriers.
The structure of PLGA scaffolds
To determine whether our PLGA scaffolds were able to form 
an optimal structural environment for the seeded NSCs, 
we examined the architecture of the scaffolds under SEM. 
The PLGA rods had an average length of 2 mm, and an 
  average diameter of 5 mm. Tubes in each rod were 0.5 mm 
in diameter (arrow in Figure 1E). Numerous pores with 
diameters from 200 µm to 300 µm were dispersed in the 
PLGA scaffold. High magnification SEM of a longitudinal 
PLGA section showed many channels (arrow in Figure 1F) 
radially extended from the tube, with many small pores 
distributed in their walls.
Bioactivity of NT-3 released  
from PLGA carriers
To determine whether bioactive NT-3 can be released 
from PLGA scaffolds, we monitored levels of NT-3 in the 
medium after 1 hour to 4 weeks of culture by ELISA in each 
of the three different groups. In the PLGA-3% SF solution 
group, NT-3 release from NT-3-loaded PLGA carriers was 
t  riphasic, consisting of a typical burst of release within the 
first 6 hours, followed by a period of slow increase until day 
18, and finally a stable rate until day 35 (Figure 2A). On the 
other hand, in the PLGA-1% SF solution group, the release 
rate of NT-3 reached a peak on day 7, and thereafter began to 
decline (Figure 2B). In the PLGA-6% SF solution group, the 
release curve of NT-3 was similar to that of the PLGA-3% SF 
solution group, except for a lower level of NT-3 (Figure 2C). 
By day 35, the cumulative release of NT-3 was obviously 
highest in the PLGA-3% SF solution group. There was no 
significant difference between the PLGA-1% and -6% SF 
solution groups in the total of NT-3 released (Figure 2D). 
Taken together, these results suggest that NT-3-loaded PLGA 
carriers are an efficient way of releasing bioactive NT-3, 
and embedding NT-3 in the PLGA-3% SF solution not only 
permitted the release of more NT-3, it also ensured a stable 
and constant supply of NT-3.
Survival and differentiation of NSCs  
in NT-3-loaded PLGA carriers
To detect whether NSCs and SCs were viable in NT-3-
loaded PLGA carriers, cells grafted into the carriers were 
cultured for 14 days, and stained with calcein-AM and 
EthD-III. Viable cells exhibited green fluorescence (see 
stars in Figure 3A–C), which was generated by esterase 
hydrolysis of membrane-permeable, calcein-AM. Dead 
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Figure 2 Secretion of NT-3 from NT-3-PLGA carriers loaded with three different SF solutions groups for at least 4 weeks. Daily release of NT-3 was examined by ELISA 
in (A) the 3% SF solution group; (B) the 1% SF solution group; (C) the 6% SF solution group, respectively; and (D) There was cumulative release of NT-3 across the three 
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Note: Error bars represent mean ± SD (n = 3 for each group).
Abbreviations: NT-3, neurotrophin-3; PLGA, poly-(lactic acid-co-glycolic acid); SF, silk fibroin; ELISA, enzyme-linked immunosorbent assay.
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cells were marked by red fluorescence (see arrows in 
Figure 3A–C) from a membrane-impermeable EthD-III. 
Percentages of dead cells were not significantly differ-
ent between either the peripheral or central sections of 
the scaffolds in the PLGA-only group (2.37% ± 0.63% 
periphery; 2.54% ± 0.68% center), the PLGA-SF group 
(2.91% ± 0.72%; 2.41% ± 0.65%) and the PLGA-SF-
NT-3 group (2.36% ± 0.61%; 2.75% ± 0.74%; P . 0.05) 
(Figure 3D). These findings suggest that the survival of 
grafted cells is unaffected by their location or the nature of 
any extracellular matrix like SF.
To determine the differentiation of seeded NSCs in 
the NT-3-loaded PLGA carriers, we stained cells with 
differentiation markers, and found that the NSCs differ-
entiated into all three major CNS cell types: neurons (see 
arrow in Figure 4A–C; green), astrocytes (Figure 4A–C 
and the stars in Supplementary Figure S1A–C; red), and 
oligodendrocytes (see arrow in Supplementary Figure 
S1A–C; green). At day 14, 15.28% of 587 counted cells 
were Map2-positive in the PLGA-only group (Figure 4A, 
and Table 1), as were 21.37% of 603 in the PLGA-SF 
group (Figure 4B), and 81.15% of 623 in the PLGA-SF-
NT-3 group (Figure 4C and D). The percentage of GFAP-
positive cells was the lowest in the PLGA-SF-NT-3 group, 
compared with others (  Figure 4D). Protein levels of Map2 
or GFAP were determined using Western blotting. As 
shown in Figure 4E–H, expression of TuJ-1, the marker 
of neurons, was significantly higher in the PLGA-SF-
NT-3 group (P , 0.05; Figure 4E and F), but the level 
of GFAP was lower than in the other groups (P , 0.05; 
Figure 4G and H).
Taken together, the microenvironment in our scaffolds 
not only permitted grafted cells to survive, but also improved 
neuronal differentiation when NSCs and SCs were coseeded 
into NT-3-loaded PLGA carriers.
Synaptogenesis of NSCs
Double-immunostaining for synapsin-I and postsynaptic 
density-95 (PSD95) markers for pre- and postsynapse was 
used to determine whether NSCs and SCs in the NT-3-loaded 
PLGA carriers had developed synapses. PSD95 was mainly 
detected in the cell bodies, and synapsin-I was expressed 
in both perikaryon and neurites. As shown in Figure 5, 
there were three patterns of PSD95 (arrow) and synapsin-I 
(star) distribution: (1) cells positive for either PSD95 or 
synapsin (Figure 5A–C); (2) cells positive for both PSD95 
and synapsin-I (Figure 5C); (3) cells with positive PSD95-
staining in the body, but receiving synapsin-positive neurites, 
or extending neurites with positive synapsin (Figure 5C). 
In the PLGA-SF-NT-3 group, the percentage of PSD95- or 
synapsin-positive cells (21.45% and 28.31%, respectively) 
was significantly higher compared to other groups (P , 0.05; 
Figure 5D). Interestingly, there were more cells positive 
for synapsin-I than cells expressing PSD95. These results 
indicate that neurons are able to form synapses in PLGA-
SF-NT-3 scaffolds.
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To further examine the formation of intercellular synapses 
among grafted cells, TEM was performed on the PLGA-cell 
constructs. Three PLGA slices were taken from each experi-
mental group, and 5–6 random fields were taken in each sample 
under TEM. TEM showed that both neurons and glial cells had 
distinguishing morphological features. In general, neurons 
have nuclei with a lower electron density and well-demarcated 
nucleoli. Figure 5E shows a typical neuron extending neurites 
from soma, and connecting to a neurite from another cell. 
Under higher magnification (Figure 5F), this connection 
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Figure 4 Differentiation detection of grafted NSCs. Cells were immunostained with markers for neurons in PLGA only. (A) PLGA-SF; (B) PLGA-SF-NT-3; (C) group (Map2; 
arrows in (A–C) green), astrocytes (GFAP; stars in A–C = red). The nuclei were labeled by DAPI (=blue); (D) Compared with other groups, cells expressing Map2 in the 
PLGA-SF-NT-3 group were significantly higher than any other groups (P , 0.05; n = 3 for each group). Cells positive for GFAP were much less. By contrast, astrocytes were 
abundant in both the PLGA and PLGA-SF groups. Scale bar = 20 µm in (A–C). Cells collected from the slices were lysed, and proteins were extracted for Western blotting 
analysis; (E) Levels of TuJ-1 expression appeared higher in the PLGA-SF-NT-3 group than those in the PLGA, or PLGA-SF groups. Proteins extracted from the rat brain 
were used as a positive control (brain); (F) Quantification of TuJ-1 blot normalized against GAPDH. (P , 0.05; n = 3 for each group); (G) Western blotting against GFAP; 
(H) Quantitative analysis showed that the level of GFAP in the PLGA-SF-NT-3 was lower than that of any other groups (P , 0.05; n = 3 for each group). Stars in (D), (F), 
and (H) indicate P , 0.05 when PLGA-SF-NT-3 versus PLGA or PLGA-SF.
Abbreviations: NSCs, neural stem cells; PLGA, poly-(lactic acid-co-glycolic acid); SF, silk fibroin; NT-3, neurotrophin-3; Map2, microtubule-associated protein 2; GFAP, glial 
fibrillary acidic protein; DAPI, 4′,6-diamidino-2-phenylindole; TuJ-1, neuron-specific class III beta-tubulin; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase.
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showed typical synaptic features, including specialized high-
density pre- and postsynaptic membrane, synaptic cleft, and 
vesicles on its terminal (arrow in Figure 5F). These results 
were consistent with that of double-immunohistochemistry, 
and suggest that synaptic formation is likely to be optimal 
in the presence of NT-3, which is released from both NT-3-
loaded PLGA scaffold and SCs.
Synaptic activity of differentiated NSCs
Due to the presence of synaptic structures in the PLGA-SF-
NT-3 group, we then decided to test whether these synaptic 
structures were functional. Cells cultured in the scaffold 
for 14 days were preloaded with FM1-43 or FM4-64, 
which stained recycling synaptic vesicles from endocytosis 
under depolarizing conditions (50 mM [K+]).21,22 In order 
to eliminate nonspecific labeling on the plasma membrane 
of neuronal cell body, cells in the PLGA scaffolds were 
rinsed extensively with PBS after the preloading process. 
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Figure 5 Synaptic formation of culture cells in the NT-3-PLGA carriers. Cells were immunostained with antibodies against pre- and postsynaptic markers (PSD95 versus 
synapsin). Nuclei were labeled by DAPI (blue). (A) Only a few cells expressed synapsin (stars in A–C = green) and PSD95 (arrows in A–C = red) in the PLGA group. PSD95 
was localized in the cell body; whereas synapsin was expressed in both the cell body and neurite; (B) Synapsin- or PSD95-positive cells were sparse in the PLGA-SF group; 
(C) In the PLGA-SF-NT3 group, the cells expressed (1) cells positive for either PSD95 or synapsin; (2) cells positive for both PSD95 and synapsin; (3) cells with positive 
PSD95-staining in the body, but receiving synapsin-positive neurites extending from another cell; (D) Cells with staining of PSD95 and synapsin were manually counted. 
Compared with other groups, positively stained cells (Synapsin+ or PSD95+) in the PLGA-SF-NT3 group were significantly higher than any other groups (P < 0.05; the star in 
D indicates P , 0.05 when PLGA-SF-NT-3 versus PLGA or PLGA-SF); (E) Under transmission electron microscopy (TEM), a neuron was identified in PLGA-SF-NT-3 group. 
Note the neurite extending from the soma of one cell and connecting to a neutrite of another cell. (F) High magnification TEM of synapse formation in cultured cells, revealing 
specialized high-density pre- and postsynaptic membrane, synaptic cleft, and vesicles in its terminal.
Note: Scale bar = 20 µm in A–C, 200 nm in F.
Abbreviations: NT-3, neurotrophin-3; PLGA, poly-(lactic acid-co-glycolic acid); PSD95, postsynaptic density-95; DAPI, 4′,6-diamidino-2-phenylindole; SF, silk fibroin.
Table 1 Comparison of cell-types (mean ± SD %) among different 
groups
Groups n Map2 GFAP O4
PLGAa 3 15.28 ± 2.75 76.57 ± 3.56 7.53 ± 1.36
PLGA-SFb 3 21.37 ± 3.89 71.21 ± 4.75 6.41 ± 2.04
PLGA-SF-NT-3c 3 81.15 ± 4.99 11.35 ± 4.86 7.12 ± 1.83
Notes: One-way analysis of variance was used to show the statistical difference. 
Map2: P , 0.05 a versus b; a versus c; b versus c; GFAP: P , 0.05 a versus c; b versus c; 
P . 0.05 a versus b; O4: P . 0.05 a versus b; a versus c; b versus c. a, b, and c in 
the table represent PLGA,  PLGA-SF, and PLGA-SF-NT-3 group, respectively.
Abbreviations: Map2, microtubule-associated protein; GFAP, glial fibrillary acidic 
protein; PLGA, poly-(lactic acid-co-glycolic acid); SF, silk fibroin; NT-3, neurotrophin-3.
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A second depolarization was then induced by raising the 
K+ concentration, which led to the release of FM1-43 or 
FM4-64 by exocytosis (Figure 6). At the beginning of 
K+ stimulation, plenty of fluorescent puncta (FM1-43 or 
FM4-64) appeared in the neurites, particularly at the sites 
where neurites crossed over each other in the PLGA-SF-
NT-3 group (see arrow in Figure 6A and E). By contrast, 
barely detectable fluorescent puncta appeared in the 
PLGA-only group after preloading (Figure 6C), suggesting 
dramatically reduced endocytosis of puncta in this group. 
When cells were subjected to continuous stimulation for 
3 minutes, fluorescent puncta disappeared or reduced in 
intensity in many neurites in the PLGA-SF-NT-3 group (see 
arrows in Figure 6B, and F). However, in the PLGA-only 
group, fluorescence intensity and distribution remained 
unchanged (Figure 6D).
To quantitatively track the changes of fluorescence 
intensity, we next used fluorescence microscopy to continu-
ously record preloaded cells for 5 minutes in the PLGA-SF-
NT-3 group. A decline in FM1-43 intensity was observed in 
several waves during this process (Figure 6G). These results 
suggest that synaptic vesicles in our cultured neurons are 
able to fuse with the plasma membrane, with their contents 
diffusing into the pericellular compartment.21,22 By contrast, 
neuronal cell bodies used as an experimental control showed 
no apparent change of fluorescence over time (see arrow in 
Figure 6G).
Myelination of grafted cells
To determine whether neurites become myelinated by 
coseeded SCs in the PLGA scaffolds, we performed 
respective double-immunostaining for Map2 and MBP, 
the markers for neuron and myelin sheaths. As shown in 
Figure 7, MBP-positive fibers (arrows in Figure 7A–C; 
green) costained with neurites (red) were evident in our 
coculture system. The percentage of MBP-positive fibers 
was significantly higher in the PLGA-SF-NT-3 group, 
compared with others (P , 0.05; Figure 7D). This finding 
indicates the development of robust myelin structures in 
the PLGA-SF-NT-3 group. Furthermore, EM images of 
cultured neurons clearly reveal the presence of a myelin 
sheath (Figure 7E), which as seen is typically composed 
of several layers wrapping around axons in the PLGA-SF-
NT-3 group (Figure 7F).
Discussion
Repairing neuronal circuits after SCI remains a significant 
challenge, due to the permanent disruption of descending/
ascending pathways caused by host cell death and tissue 
disorganization, including demyelination. Although resident 
endogenous NSCs exist on the central canal lining of the 
adult spinal cord,23 their recruitment is limited in response 
to injury.24 Exogenous NSCs transplantation was proposed 
to be a strategy for spinal cord regeneration.3,12,21 However, 
whether these grafted cells are able to survive, differentiate 
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Figure 6 Release of synaptic vesicles during depolarization by high [K+]. (A) In the PLGA-SF-NT-3 group, FM1-43 fluorescent puncta were particularly concentrated at sites 
where neurites crossed over (see arrows) under stimulation of high [K+] (50 mM); (B) After 3-minute stimulation by the high [K+], fluorescence intensity of these puncta 
was weakened or disappeared; (C) By contrast, uptake of the fluorescent signal into the cells in the NSCs group was only minimal, and showed weak fluorescence prior to 
three-minute stimulation; (D) Fluorescence intensity remained unchanged after the stimulation period; (E) FM4-64 fluorescent puncta before; and (F) after stimulation of 
high [K+]; (G). FM1-43 fluorescence was tracked on the cells in the PLGA-SF-NT-3 group, which was continuously depolarized for 5 minutes. Recording from the cytoplasm 
was used as a control, and showed no significant change over the 5-minute period (arrow in G).
Abbreviations:  PLGA,  poly-(lactic  acid-co-glycolic  acid);  SF,  silk  fibroin;  NT-3,  neurotrophin-3;  NSCs,  neural  stem  cells;  FM1-43,  [(N-3-triethylammonmpropyl)-4-
(4-(dibutylamino)styryl)]; FM4-64, [N-(3-triethylammoniumpropyl)-4-(6-(4-(diethylamino)phenyl) hexatrienyl)pyridiniumdibromide].
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Figure 7 Formation of myelin sheath in the coculture system. NSCs and SCs in the cells/PLGA were cultured for 14 days, and immunostained with antibodies against neuron 
and myelin sheath markers (Map2 = red versus MBP = green). Nuclei were labeled by DAPI (blue). (A) Arrow indicates segments of neuronal axons wrapped by (MBP-
positive) myelin sheath in PLGA; (B) the PLGA-SF group; and (C) PLGA-SF-NT-3 group, respectively; (D) Abundance of MBP-positive fibers in the PLGA-SF-NT-3 group 
compared with other groups (P , 0.05; n = 3 for each group); (E) TEM showing formation of the myelin sheath in the PLGA-SF-NT-3 group; (F) Typical, characteristic sheath 
composed of several layers wrapped around axons. 
Note: Scale bar = 20 µm in (A–C), 200 nm in (F).
Abbreviations: NSCs, neural stem cells; SCs, Schwann cells; PLGA, poly-(lactic acid-co-glycolic acid); SF, silk fibroin; NT-3, neurotrophin-3; Map2, microtubule-associated 
protein 2; MBP, myelin basic protein; TEM, transmission electron microscopy.
into neurons, form myelin structures, and then re-establish a 
functioning neuronal network, remains unknown.
In  this  study,  we  cocultured  NSCs  and  SCs  in 
NT-3-loaded PLGA carriers, and systemically investigated 
the survival and differentiation of cultured cells in relation 
to the nature of the scaffold matrix. Recent approaches 
employed for neuronal culture have aimed at embedding or 
encapsulating neurotrophic factors into a polymer13,20,21 or 
protein matrix25 to treat SCI. SF has already exhibited excel-
lent biocompatibility both in vitro25,26 and in vivo,27 good 
mechanical properties,28 and a slow rate of biodegradation. 
Embedding NTs into SF is considered a viable strategy for 
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long-term NT release.25 Our study exhibited excellent release 
of NT-3 from NT-3-loaded PLGA carriers. We found that 
NT-3 release persists for longer than 4 weeks. This is consis-
tent with recent studies reporting that bioactive NT-3 can be 
detected from 1 hour to 4 weeks due to its embedding into 
chitosan carriers.13,20 Our experiment not only demonstrates 
a stable and constant rate of NT-3 release, it also provides a 
suitable concentration of SF solution for the embedding of 
neurotrophic factors.
Different NT-3 release profiles were observed when 
equal amounts of NT-3 were embedded into three different 
concentrations of SF solution. This may be due to the strong 
interaction between NT-3 and SF, owing to the opposite 
charge of two proteins. The fact that cumulative NT-3 release 
is highest in the case of the 3% SF solution may be due to 
the stronger interaction between NT and SF in the 6% SF 
solution, whereas in the 1% SF solution, much less NT was 
sequestered in the first place. Thanks to the constant release 
of NT, our data showed excellent survival of grafted cells 
(dead cells were ,4%), and demonstrated a uniform sur-
vival rate in both the peripheral and central sections of the 
slices from the three scaffold types. Taken together, these 
findings suggest a promising NT-3 delivery system, which 
will benefit both neural survival and the differentiation of 
grafted cells.
Our data clearly showed that the majority of NSCs dif-
ferentiated into neurons in NT-3-loaded PLGA carriers. 
More importantly, these neurons also exhibited synaptic 
plasticity, formed synapses and myelin sheaths with SCs, 
and established a functional neural construction in vitro. 
This premise is supported by several lines of evidence. 
(1) morphology of synaptic structures and myelination was 
observed by the use of TEM and double-immunostaining; 
(2) the synaptic structures were excitable when subjected to 
external stimuli (ie, a high K+ concentration). We found that 
synaptic vesicles tracked by fluorescence dye (FM1-43 or 
FM4-64) were released upon depolarization.
Neuronal differentiation is a prerequisite for construct-
ing a neural network in vitro. In our study, NSCs showed 
different degrees of differentiation in the three coculture 
conditions. In the PLGA-SF-NT-3 group, the percentage 
of Map2-positive cells was higher than in the other groups 
(81.15% versus 15.28% and 21.37%, respectively). On the 
contrary, the percentage of GFAP-positive cells was lower. 
These findings are further supported by the blot detection of 
TuJ-1 and GFAP. Similar results have also been reported in 
others’ earlier works.13,20
Furthermore, it is well-known that extracellular matrix 
(ECM) components play a role in the differentiation of 
NSCs into neurons.29,30 Our data showed that the rate of 
Map2-positive cells was higher in the PLGA-SF group than 
in the PLGA-only group. These results not only demonstrated 
the known function of NT-3 in neuronal survival and differ-
entiation, but also suggested that SF may contribute to the 
differentiation of neurons.
The presence of double-immunostaining on cultured cells 
showed a robust signal against synaptic markers, synapsin 
and PSD95. Percentages of either synapsin- or PSD95-
positive cells were highest in the PLGA-SF-NT-3 group. 
This suggests that abundant synaptic connections are formed 
inside PLGA scaffolds, which is also consistent with the 
role of NTs in synaptic formation.18 Furthermore, electron 
microscopy studies showed the presence of mature synapses, 
including specialized, high-density pre- and postsynaptic 
membrane, synaptic cleft, and vesicles in its terminal.
To test whether these synaptic connections are func-
tional, we used two different fluorescent dyes, FM1-43 and 
FM4-64, to specifically label synaptic vesicles under high K+ 
depolarization conditions,31,32 and followed the fluorescent 
intensity of neuritis during a second depolarization. We 
observed that the fluorescent intensity of FM1-43-labeled 
neuritis during exocytosis gradually decreased, and fluores-
cent puncta disappeared at sites where neurites crossed over. 
Similar observations were also made by FM4-64 labeling. 
By contrast, the rate of FM1-43 fluorescent puncta uptake 
into NSCs was only minimal, and its intensity did not change 
during depolarization. Taken all together, these results sug-
gest that the coseeding of NSCs and SCs into NT-3-loaded 
PLGA carriers produces abundant synaptic connections, 
and these synaptic connections show activity in response to 
external stimuli.
Axon myelination facilitates neuronal performance 
by increasing the speed of neuronal conductance. Some 
studies also support the key role of remyelination in pro-
moting neuronal survival after injury to adult CNS.33 In 
the present study, abundant myelin sheaths were identified 
by double-immunostaining in the PLGA-SF-NT-3 group, 
but not in the control groups. Furthermore, the formation 
of myelin structure was also supported by EM analysis, 
which revealed robust myelinated axons in the PLGA-SF-
NT-3 group.
Conclusion
In the present study, we successfully constructed a pro-
tein delivery system in vitro, which releases bioactive 
NT-3 stably and constantly. Coseeding NSCs and SCs into 
these NT-3-loaded PLGA carriers not only permitted sur-
vival of grafted cells, but also promoted the differentiation 
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of NSCs into neurons. These neurons developed synaptic 
connections, exhibited synaptic activities, and became 
myelinated by coseeded SCs on their neurites. These findings 
provide functional neural constructs to serve as potential 
conduits in neural repair. Our ongoing study will now focus 
on the evaluation of new construction in an in vivo model 
of SCI, to promote the recovery of both motor and sensory 
functions.
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Figure S1 NSCs and SCs were cultured in the scaffold for 14 days. Cells were immunostained in (A) PLGA only; (B) PLGA-SF; (C) PLGA-SF-NT-3 group with markers for 
astrocytes (GFAP; star; red), and oligodendrocytes (O4; arrow; green). Nuclei were stained by DAPI (blue); (D) Cells with staining of O4 were manually counted. There was 
no statistical difference among groups (P . 0.05; n = 3 for each group).
Note: Scale bar = 20 µm in A–C.
Abbreviations: NSCs, neural stem cells; SCs, Schwann cells; PLGA, poly-(lactic acid-co-glycolic acid); SF, silk fibroin; NT-3, neurotrophin-3; GFAP, glial fibrillary acidic 
protein; DAPI, 4′,6-diamidino-2-phenylindole.
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